TRANSTORNO COMPORTAMENTAL DO SONO REM: ABORDAGENS TERAPÊUTICAS EMERGENTES

Authors

  • Jamilton Jesus Santos Junior Graduanda em Medicina pela União Metropolitana de Educação e Cultura
  • Lorena Gabryelly da Silva Alves Graduando em Medicina pela Universidade Tiradentes - Aracaju
  • Edney Marcelo de Melo Aragão Júnior Graduando em Medicina pelo Centro de Estudos Superiores de Maceió
  • Rinaldo Rocha de Lucena Filho Graduando em Medicina pela Faculdade de Ciências Médicas - Jaboatão
  • Paulo Sérgio de Souza Larrea Graduada em Medicina pela Universidade Federal da Grande Dourados
  • Rhayran Espindola Rodrigues Graduada em Medicina pela Universidade Federal da Grande Dourados
  • Julianna Miranda Gomes Graduada em Medicina pela FAHESP/IESVAP- Instituto de Educação Superior do Vale do Parnaíba
  • Amanda Virgínia Oliveira Leite Graduada em Medicina pela Faculdade de Medicina de Olinda
  • Leonardo Mota Silva Graduando em Medicina pelo Centro de Estudos Superiores de Maceió
  • Markos Paulo Alves Ferreira Graduando em Medicina pelo Centro de Estudos Superiores de Maceió
  • Martha de Araujo Medeiros Pereira Graduada em Medicina pelo Centro de Estudos Superiores de Maceió
  • Lucas Gabriel Lopes Donato Graduando em Medicina pelo Centro Universitário de Maceió
  • Ernesto Brandão de Albuquerque Maranhão Graduando em Medicina pelo Centro Universitário de Maceió

DOI:

https://doi.org/10.36557/pbpc.v3i2.116

Keywords:

REM sleep behavior disorder, REMSD, treatment

Abstract

Introduction: Rapid Emerging Respiratory Behavior Disorder (REMBD) is a parasomnia characterized by the absence of normal muscle atonia during REM sleep, resulting in complex and vivid motor behaviors, often associated with dreams. Methods: This is an integrative review conducted through the Scopus, PubMed® and SciELO databases, using the descriptors REM sleep behavioral disorder, REMBD and treatment. Studies published in the last 13 years, in English, Spanish or Portuguese, that addressed the topic were included. Results and discussions: The treatment of REMBD includes environmental safety measures and the suspension of certain medications and alcohol. Clonazepam and melatonin are the main drugs used, with melatonin being preferred due to its mild adverse effects. Other options, such as rivastigmine and memantine, are used when necessary. The approach should be personalized, considering efficacy and tolerability. Conclusion: The therapeutic approach to REMBD should be carefully individualized to meet the specific needs of each patient. It is essential to consider the effectiveness of the proposed treatments, evaluating which medications or combinations of medications provide the greatest relief of symptoms with the least adverse effects. The tolerability of treatments is equally important, since patients may react differently to different therapies and may have specific limitations or contraindications.

Downloads

Download data is not yet available.

References

BOEVE, B. F. et al. Clinicopathologic correlations in 172 cases of rapid eye movement sleep behavior disorder with or without a coexisting neurologic disorder. Sleep Medicine, v. 14, n. 8, p. 754–762, 2013.

BREEN, D. P. et al. Sleep and circadian rhythm regulation in early Parkinson disease. JAMA Neurology, v. 71, n. 5, p. 589–595, 2014.

BRUNETTI, V. et al. Rivastigmine for refractory REM behavior disorder in mild cognitive impairment. Current Alzheimer Research, v. 11, n. 3, p. 267–273, 2014.

CLAASSEN, D. O. et al. REM sleep behavior disorder preceding other aspects of synucleinopathies by up to half a century. Neurology, v. 75, n. 6, p. 494–499, 2010.

DI GIACOPO, R. et al. Rivastigmine as alternative treatment for refractory REM behavior disorder in Parkinson’s disease. Movement Disorders: Official Journal of the Movement Disorder Society, v. 27, n. 4, p. 559–561, 2012.

FERNANDEZ-ARCOS, A. et al. The Clinical Phenotype of Idiopathic Rapid Eye Movement Sleep Behavior Disorder at Presentation: A Study in 203 Consecutive Patients. Sleep, v. 39, n. 1, p. 121–132, 2016.

HANCOCK, K. L. et al. Quantitative analyses of REM sleep without atonia in children and adolescents with REM sleep behavior disorder. Minn Med, v. 97, n. 5, p. 43, 2014.

IRANZO, A. et al. Neurodegenerative disorder risk in idiopathic REM sleep behavior disorder: study in 174 patients. PLoS One, v. 9, n. 2, e89741, 2014.

JUN, J. S. et al. Prolonged-release melatonin in patients with idiopathic REM sleep behavior disorder. Annals of Clinical and Translational Neurology, v. 6, n. 4, p. 716–722, 2019.

KANG, S. H. et al. REM sleep behavior disorder in the Korean elderly population: prevalence and clinical characteristics. Sleep, v. 36, n. 8, p. 1147–1152, 2013.

LI, S. X. et al. A prospective, naturalistic follow-up study of treatment outcomes with clonazepam in rapid eye movement sleep behavior disorder. Sleep Medicine, v. 21, p. 114–120, 2016.

LIEBENTHAL, J. et al. A Case of Rapid Eye Movement Sleep Behavior Disorder in Parkinson Disease Treated With Sodium Oxybate. JAMA Neurology, v. 73, n. 1, p. 126–127, 2016.

MA, C. et al. Alcohol consumption and probable rapid eye movement sleep behavior disorder. Annals of Clinical and Translational Neurology, v. 5, n. 10, p. 1176–1183, 2018.

MCCARTER, S. J. et al. Treatment outcomes in REM sleep behavior disorder. Sleep Medicine, v. 14, n. 3, p. 237–242, 2013.

MCGRANE, I. R. et al. Melatonin therapy for REM sleep behavior disorder: a critical review of evidence. Sleep Medicine, v. 16, n. 1, p. 19–26, 2015.

PFEFFER, M.; KORF, H. W.; WICHT, H. Synchronizing effects of melatonin on diurnal and circadian rhythms. General and Comparative Endocrinology, v. 258, p. 215–221, 2018.

POSTUMA, R. B. et al. Risk factors for neurodegeneration in idiopathic rapid eye movement sleep behavior disorder: a multicenter study. Ann Neurol, v. 77, n. 5, p. 830–839, 2015.

SCHENCK, C. H.; BOEVE, B. F.; MAHOWALD, M. W. Delayed emergence of a parkinsonian disorder or dementia in 81% of older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder: a 16-year update on a previously reported series. Sleep Medicine, v. 14, n. 8, p. 744–748, 2013.

TANG, W. K. et al. Brainstem infarcts predict REM sleep behavior disorder in acute ischemic stroke. BMC Neurology, v. 14, p. 88, 2014.

TINUPER, P.; BISULLI, F.; PROVINI, F. The parasomnias: mechanisms and treatment. Epilepsia, v. 53, Suppl 7, p. 12–19, 2012.

VENDETTE, M. et al. Brain perfusion and markers of neurodegeneration in rapid eye movement sleep behavior disorder. Movement Disorders, v. 26, n. 9, p. 1717–1724, 2011.

Downloads

Published

2024-08-15

How to Cite

JUNIOR , Jamilton Jesus Santos et al. TRANSTORNO COMPORTAMENTAL DO SONO REM: ABORDAGENS TERAPÊUTICAS EMERGENTES. Periódicos Brasil. Pesquisa Científica, Macapá, Brasil, v. 3, n. 2, p. 1142–1151, 2024. DOI: 10.36557/pbpc.v3i2.116. Disponível em: https://periodicosbrasil.emnuvens.com.br/revista/article/view/116. Acesso em: 27 sep. 2025.

Issue

Vol. 3 No. 2 (2024): PBPC 2024

Section

Ciências da Saúde

License

Copyright (c) 2024 Jamilton Jesus Santos Junior , Lorena Gabryelly da Silva Alves , Edney Marcelo de Melo Aragão Júnior , Rinaldo Rocha de Lucena Filho , Paulo Sérgio de Souza Larrea , Rhayran Espindola Rodrigues , Julianna Miranda Gomes , Amanda Virgínia Oliveira Leite , Leonardo Mota Silva, Markos Paulo Alves Ferreira, Martha de Araujo Medeiros Pereira , Lucas Gabriel Lopes Donato , Ernesto Brandão de Albuquerque Maranhão

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Você tem o direito de:

  1. Compartilhar — copiar e redistribuir o material em qualquer suporte ou formato para qualquer fim, mesmo que comercial.
  2. Adaptar — remixar, transformar, e criar a partir do material para qualquer fim, mesmo que comercial.
  3. O licenciante não pode revogar estes direitos desde que você respeite os termos da licença.  

 

De acordo com os termos seguintes:

  1. Atribuição — Você deve dar o crédito apropriado , prover um link para a licença e indicar se mudanças foram feitas . Você deve fazê-lo em qualquer circunstância razoável, mas de nenhuma maneira que sugira que o licenciante apoia você ou o seu uso.
  2. Sem restrições adicionais — Você não pode aplicar termos jurídicos ou medidas de caráter tecnológico que restrinjam legalmente outros de fazerem algo que a licença permita.